Details of the Drug Combinations

General Information of This Drug (ID: DM0HXDS)

Drug Name
Pentostatin   DM0HXDS
Synonyms
Coforin; Covidarabine; Deoxycoformycin; Nipent; Oncopent; Vidarbine; Vira A deaminase inhibitor; CL-67310465; CO-Vidarabine; Co-V; Nipent (TN); PD-81565; PD-ADI; Pentostatin (JAN/USAN/INN); (8R)-3-(2-deoxy-beta-D-erythro-pentofuranosyl)-3,6,7,8-tetrahydroimidazo[4,5-d][1,3]diazepin-8-ol; (8R)-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-7,8-dihydro-4H-imidazo[4,5-d][1,3]diazepin-8-ol; (R)-3-(2-Deoxy-.beta.-D-erythro-pentofuranosyl)-3,6,7,8-tetrahydroimidazo(4,5-d)(1,3)diazepin-8-ol; 2'-DCF; 2'-Deoxycoformycin; 2'-Dexoycoformycin
Indication
Disease Entry ICD 11 Status REF
Acute graft versus host disease 4B24.0 Approved [1]
Hairy cell leukaemia 2A82.2 Approved [2]
Leukemia N.A. Approved [1]
Therapeutic Class
Anticancer Agents
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL

List of Combinatorial Drugs (CBD) Containing This Drug

456 Investigative Drug Combination(s) Consisting of This drug
Normalized Drug Combination Synergy Score
Synergy scores were normalized using Min-Max Scaling to facilitate visual comparisons.
DrugCom Name DrugCom ID Component Drug Indication REF
ABIRATERONE + Pentostatin DCGLYYH ABIRATERONE Clear cell renal cell carcinoma (Cell Line: A498) [3]
ABIRATERONE + Pentostatin DCEJEU3 ABIRATERONE Renal cell carcinoma (Cell Line: UO-31) [3]
ABIRATERONE + Pentostatin DCO9V7V ABIRATERONE Breast adenocarcinoma (Cell Line: MDA-MB-468) [4]
ABIRATERONE + Pentostatin DCFVFCC ABIRATERONE Colon adenocarcinoma (Cell Line: COLO 205) [4]
ABIRATERONE + Pentostatin DCLNQLX ABIRATERONE Adenocarcinoma (Cell Line: DU-145) [5]
ABIRATERONE + Pentostatin DCC5YWI ABIRATERONE Cutaneous melanoma (Cell Line: SK-MEL-5) [5]
ABIRATERONE + Pentostatin DC9RPSD ABIRATERONE Malignant melanoma (Cell Line: LOX IMVI) [5]
ABIRATERONE + Pentostatin DCKY0FX ABIRATERONE Melanoma (Cell Line: SK-MEL-2) [5]
Acamprosate + Pentostatin DCW4ZKI Acamprosate Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Altretamine + Pentostatin DC3HHS4 Altretamine Adenocarcinoma (Cell Line: NCIH23) [3]
Altretamine + Pentostatin DC4NT5O Altretamine Adenocarcinoma (Cell Line: HCC-2998) [3]
Altretamine + Pentostatin DCTINOY Altretamine Chronic myelogenous leukemia (Cell Line: K-562) [3]
Aminolevulinic Acid Hydrochloride + Pentostatin DCEGBRN Aminolevulinic Acid Hydrochloride Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [3]
Aminolevulinic Acid Hydrochloride + Pentostatin DCVFW81 Aminolevulinic Acid Hydrochloride Papillary renal cell carcinoma (Cell Line: ACHN) [3]
Aminolevulinic Acid Hydrochloride + Pentostatin DC1B7TL Aminolevulinic Acid Hydrochloride Plasma cell myeloma (Cell Line: RPMI-8226) [3]
Aminolevulinic Acid Hydrochloride + Pentostatin DCX1T1T Aminolevulinic Acid Hydrochloride Colon carcinoma (Cell Line: KM12) [4]
Aminolevulinic Acid Hydrochloride + Pentostatin DCXMCQM Aminolevulinic Acid Hydrochloride Invasive ductal carcinoma (Cell Line: HS 578T) [4]
Aminolevulinic Acid Hydrochloride + Pentostatin DCLHD5N Aminolevulinic Acid Hydrochloride Adenocarcinoma (Cell Line: NCIH23) [5]
Aminolevulinic Acid Hydrochloride + Pentostatin DCLCIIV Aminolevulinic Acid Hydrochloride Amelanotic melanoma (Cell Line: MDA-MB-435) [5]
Aminolevulinic Acid Hydrochloride + Pentostatin DCXM8OJ Aminolevulinic Acid Hydrochloride Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [5]
Amonafide + Pentostatin DCJ7M0D Amonafide Clear cell renal cell carcinoma (Cell Line: 786-0) [3]
Anastrozole + Pentostatin DC53KU2 Anastrozole Adenocarcinoma (Cell Line: A549) [3]
Anastrozole + Pentostatin DCW6IWM Anastrozole Adenocarcinoma (Cell Line: HCC-2998) [3]
Anastrozole + Pentostatin DC98D6N Anastrozole Cutaneous melanoma (Cell Line: SK-MEL-28) [3]
Anastrozole + Pentostatin DC8YF3F Anastrozole High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [3]
Anastrozole + Pentostatin DC9BRGC Anastrozole Melanoma (Cell Line: UACC-257) [3]
Anastrozole + Pentostatin DCUZKXI Anastrozole Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [3]
Anastrozole + Pentostatin DCLQ2AB Anastrozole Invasive ductal carcinoma (Cell Line: BT-549) [4]
Azacitidine + Pentostatin DC3EGEU Azacitidine Anaplastic large cell lymphoma (Cell Line: SR) [3]
Azacitidine + Pentostatin DCV1KM4 Azacitidine Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [3]
Azacitidine + Pentostatin DC5WFM7 Azacitidine Colon adenocarcinoma (Cell Line: COLO 205) [4]
Bleomycin + Pentostatin DCX5DQI Bleomycin Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [3]
Bleomycin + Pentostatin DCA9NVF Bleomycin Chronic myelogenous leukemia (Cell Line: K-562) [3]
Bleomycin + Pentostatin DC9CC3Q Bleomycin Breast adenocarcinoma (Cell Line: MDA-MB-468) [4]
Bleomycin + Pentostatin DCHMXYA Bleomycin Colon adenocarcinoma (Cell Line: COLO 205) [4]
Bleomycin + Pentostatin DCKU75S Bleomycin Invasive ductal carcinoma (Cell Line: T-47D) [4]
Bleomycin + Pentostatin DC254CB Bleomycin Adenocarcinoma (Cell Line: OVCAR3) [5]
Bosentan + Pentostatin DCVITCU Bosentan Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Busulfan + Pentostatin DCNHN2U Busulfan Adenocarcinoma (Cell Line: HCT116) [3]
Busulfan + Pentostatin DCTJCZ3 Busulfan Glioblastoma (Cell Line: SNB-75) [3]
Busulfan + Pentostatin DCSG3GC Busulfan Glioma (Cell Line: SF-539) [3]
Busulfan + Pentostatin DCTKFO6 Busulfan Colon adenocarcinoma (Cell Line: COLO 205) [4]
Busulfan + Pentostatin DCXFPLJ Busulfan Colon carcinoma (Cell Line: KM12) [4]
Cabazitaxel + Pentostatin DC9IVOT Cabazitaxel Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Cabazitaxel + Pentostatin DC74TNP Cabazitaxel Anaplastic large cell lymphoma (Cell Line: SR) [3]
Cabazitaxel + Pentostatin DCEPKT6 Cabazitaxel Clear cell renal cell carcinoma (Cell Line: A498) [3]
Cabazitaxel + Pentostatin DC7EWFK Cabazitaxel Breast adenocarcinoma (Cell Line: MDA-MB-468) [4]
Cabazitaxel + Pentostatin DCEPTJR Cabazitaxel Carcinoma (Cell Line: RXF 393) [4]
Cefmenoxime + Pentostatin DC5KP6O Cefmenoxime Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Cerivastatin + Pentostatin DC0HPDZ Cerivastatin Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Clindamycin + Pentostatin DCG6YKQ Clindamycin Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Crizotinib + Pentostatin DC6EG09 Crizotinib Adenocarcinoma (Cell Line: DU-145) [3]
Crizotinib + Pentostatin DC5U765 Crizotinib Amelanotic melanoma (Cell Line: M14) [3]
Crizotinib + Pentostatin DCO1Y3A Crizotinib Clear cell renal cell carcinoma (Cell Line: 786-0) [3]
Crizotinib + Pentostatin DCN64D9 Crizotinib Cutaneous melanoma (Cell Line: SK-MEL-28) [3]
Crizotinib + Pentostatin DCULBIT Crizotinib High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [3]
Crizotinib + Pentostatin DCDO3VY Crizotinib Large cell lung carcinoma (Cell Line: NCI-H460) [3]
Crizotinib + Pentostatin DCVJ0AN Crizotinib Plasma cell myeloma (Cell Line: RPMI-8226) [3]
Crizotinib + Pentostatin DCH79MW Crizotinib Invasive ductal carcinoma (Cell Line: BT-549) [4]
Crizotinib + Pentostatin DCUX2D5 Crizotinib Invasive ductal carcinoma (Cell Line: T-47D) [4]
Crizotinib + Pentostatin DCNGZL8 Crizotinib Invasive ductal carcinoma (Cell Line: HS 578T) [4]
Cyclophosphamide + Pentostatin DC5FEHQ Cyclophosphamide Astrocytoma (Cell Line: SNB-19) [3]
Cyclophosphamide + Pentostatin DC7SSQ0 Cyclophosphamide Chronic myelogenous leukemia (Cell Line: K-562) [3]
Cyclophosphamide + Pentostatin DCPFA1Y Cyclophosphamide Glioma (Cell Line: SF-295) [3]
Cyclophosphamide + Pentostatin DC4ZXCG Cyclophosphamide Glioma (Cell Line: SF-268) [3]
Cyclophosphamide + Pentostatin DCM8QX4 Cyclophosphamide Carcinoma (Cell Line: MCF7) [4]
Cyclophosphamide + Pentostatin DCEMF87 Cyclophosphamide Invasive ductal carcinoma (Cell Line: HS 578T) [4]
Dacarbazine + Pentostatin DC7C9ED Dacarbazine Amelanotic melanoma (Cell Line: M14) [3]
Dacarbazine + Pentostatin DCZSJLB Dacarbazine Clear cell renal cell carcinoma (Cell Line: 786-0) [3]
Dactinomycin + Pentostatin DCA235M Dactinomycin Invasive ductal carcinoma (Cell Line: T-47D) [4]
Dactinomycin + Pentostatin DCP4LXR Dactinomycin Invasive ductal carcinoma (Cell Line: BT-549) [4]
Dactinomycin + Pentostatin DCSM2J1 Dactinomycin Adenocarcinoma (Cell Line: A549) [5]
Dactinomycin + Pentostatin DC2H9IE Dactinomycin Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [5]
Dactinomycin + Pentostatin DC047BC Dactinomycin Clear cell renal cell carcinoma (Cell Line: CAKI-1) [5]
Dactinomycin + Pentostatin DCJI13V Dactinomycin High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4) [5]
Dactinomycin + Pentostatin DC261QC Dactinomycin Non-small cell lung carcinoma (Cell Line: HOP-92) [5]
Dactinomycin + Pentostatin DCSIKM1 Dactinomycin Papillary renal cell carcinoma (Cell Line: ACHN) [5]
Dactinomycin + Pentostatin DCUXXM2 Dactinomycin Renal cell carcinoma (Cell Line: UO-31) [5]
Dasatinib + Pentostatin DCNQ4DB Dasatinib Adenocarcinoma (Cell Line: HT29) [3]
Dasatinib + Pentostatin DC4J2C0 Dasatinib Adenocarcinoma (Cell Line: HCT116) [3]
Dasatinib + Pentostatin DC8J1JR Dasatinib Amelanotic melanoma (Cell Line: MDA-MB-435) [3]
Dasatinib + Pentostatin DCMJA8Q Dasatinib Glioma (Cell Line: SF-539) [3]
DFN-15 + Pentostatin DCGWBF5 DFN-15 Astrocytoma (Cell Line: U251) [3]
DFN-15 + Pentostatin DC6W472 DFN-15 Astrocytoma (Cell Line: SNB-19) [3]
DFN-15 + Pentostatin DCKI8XB DFN-15 Clear cell renal cell carcinoma (Cell Line: 786-0) [3]
DFN-15 + Pentostatin DCP3U3Q DFN-15 Adenocarcinoma (Cell Line: HT29) [5]
Digitoxin + Pentostatin DCAXJJR Digitoxin Adenocarcinoma (Cell Line: OVCAR3) [3]
Docetaxel + Pentostatin DCUSRS1 Docetaxel Adenocarcinoma (Cell Line: NCIH23) [3]
Doxorubicin + Pentostatin DCVR19A Doxorubicin Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Epinephrine + Pentostatin DC28MY3 Epinephrine Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Epirubicin + Pentostatin DCCTR3D Epirubicin Astrocytoma (Cell Line: SNB-19) [3]
Epirubicin + Pentostatin DCUYAUC Epirubicin Clear cell renal cell carcinoma (Cell Line: A498) [3]
Epirubicin + Pentostatin DCXP62Q Epirubicin Glioma (Cell Line: SF-268) [3]
Epirubicin + Pentostatin DCCPOOX Epirubicin Plasma cell myeloma (Cell Line: RPMI-8226) [3]
Epirubicin + Pentostatin DC713GC Epirubicin Renal cell carcinoma (Cell Line: UO-31) [3]
Epirubicin + Pentostatin DC9R313 Epirubicin Carcinoma (Cell Line: MCF7) [4]
Epirubicin + Pentostatin DCPV0K8 Epirubicin Invasive ductal carcinoma (Cell Line: HS 578T) [4]
Epirubicin + Pentostatin DCH6ISR Epirubicin Invasive ductal carcinoma (Cell Line: T-47D) [4]
Epirubicin + Pentostatin DCU7G9D Epirubicin Amelanotic melanoma (Cell Line: MDA-MB-435) [5]
Epirubicin + Pentostatin DCAD8B0 Epirubicin Cutaneous melanoma (Cell Line: SK-MEL-28) [5]
Epirubicin + Pentostatin DCW4260 Epirubicin Cutaneous melanoma (Cell Line: SK-MEL-5) [5]
Epirubicin + Pentostatin DCSFQ2N Epirubicin High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [5]
Epirubicin + Pentostatin DCS772O Epirubicin High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [5]
Epirubicin + Pentostatin DCOV7T7 Epirubicin Large cell lung carcinoma (Cell Line: NCI-H460) [5]
Epirubicin + Pentostatin DCBJC6X Epirubicin Malignant melanoma (Cell Line: LOX IMVI) [5]
Epirubicin + Pentostatin DCXURD1 Epirubicin Melanoma (Cell Line: UACC-257) [5]
Epirubicin + Pentostatin DC7XJKS Epirubicin Melanoma (Cell Line: MALME-3M) [5]
Epirubicin + Pentostatin DCCR3KI Epirubicin Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [5]
Eptifibatide + Pentostatin DCCX1UM Eptifibatide Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
ER819762 + Pentostatin DCQH0WW ER819762 Clear cell renal cell carcinoma (Cell Line: TK-10) [3]
ER819762 + Pentostatin DCXA93V ER819762 Breast adenocarcinoma (Cell Line: MDA-MB-468) [4]
ER819762 + Pentostatin DCT0635 ER819762 Carcinoma (Cell Line: MCF7) [4]
ER819762 + Pentostatin DCDGPU6 ER819762 Colon carcinoma (Cell Line: KM12) [4]
ER819762 + Pentostatin DCKTEXN ER819762 Large cell lung carcinoma (Cell Line: NCI-H460) [5]
ER819762 + Pentostatin DCHZM5E ER819762 Lung adenocarcinoma (Cell Line: MDA-MB-231) [5]
ER819762 + Pentostatin DCMEBAB ER819762 Melanoma (Cell Line: UACC-257) [5]
ER819762 + Pentostatin DCOPRC7 ER819762 Non-small cell lung carcinoma (Cell Line: HOP-92) [5]
Estramustine + Pentostatin DCD6IRM Estramustine Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [3]
Estramustine + Pentostatin DCYBVPU Estramustine Clear cell renal cell carcinoma (Cell Line: TK-10) [3]
Estramustine + Pentostatin DCZPBBD Estramustine Glioblastoma (Cell Line: SNB-75) [3]
Estramustine + Pentostatin DCU3HIR Estramustine Plasma cell myeloma (Cell Line: RPMI-8226) [3]
Estramustine + Pentostatin DCWQG7C Estramustine Carcinoma (Cell Line: RXF 393) [4]
Estramustine + Pentostatin DCPXYQ4 Estramustine Carcinoma (Cell Line: MCF7) [4]
Estramustine + Pentostatin DCIKBP8 Estramustine Colon carcinoma (Cell Line: KM12) [4]
Estramustine + Pentostatin DCG92UG Estramustine Invasive ductal carcinoma (Cell Line: HS 578T) [4]
Estramustine + Pentostatin DCJWJ1Y Estramustine Adenocarcinoma (Cell Line: NCIH23) [5]
Estramustine + Pentostatin DCWPTJB Estramustine High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4) [5]
Estramustine + Pentostatin DCTRY48 Estramustine Melanoma (Cell Line: SK-MEL-2) [5]
Fludarabine + Pentostatin DCWLUK0 Fludarabine Adenocarcinoma (Cell Line: HCT-15) [5]
Fomepizole + Pentostatin DC315YM Fomepizole Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
FORMESTANE + Pentostatin DCC7ATE FORMESTANE Adenocarcinoma (Cell Line: HCC-2998) [3]
FORMESTANE + Pentostatin DC8V3K9 FORMESTANE Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
FORMESTANE + Pentostatin DCDSRGS FORMESTANE Anaplastic large cell lymphoma (Cell Line: SR) [3]
FORMESTANE + Pentostatin DCXA4BN FORMESTANE Astrocytoma (Cell Line: U251) [3]
FORMESTANE + Pentostatin DCGE3UU FORMESTANE Glioma (Cell Line: SF-539) [3]
FORMESTANE + Pentostatin DCRCCVT FORMESTANE Lung adenocarcinoma (Cell Line: EKVX) [3]
FORMESTANE + Pentostatin DCC22L8 FORMESTANE Non-small cell lung carcinoma (Cell Line: HOP-92) [3]
FORMESTANE + Pentostatin DCO0WTC FORMESTANE Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [3]
FORMESTANE + Pentostatin DCZTJDI FORMESTANE Renal cell carcinoma (Cell Line: UO-31) [3]
Fulvestrant + Pentostatin DCE2NSP Fulvestrant Adenocarcinoma (Cell Line: HCT-15) [3]
Fulvestrant + Pentostatin DCGZH6V Fulvestrant Chronic myelogenous leukemia (Cell Line: K-562) [3]
Fulvestrant + Pentostatin DCHGK6P Fulvestrant Cutaneous melanoma (Cell Line: SK-MEL-28) [3]
Fulvestrant + Pentostatin DCE2FBZ Fulvestrant Lung adenocarcinoma (Cell Line: EKVX) [3]
Fulvestrant + Pentostatin DCTRKMQ Fulvestrant Plasma cell myeloma (Cell Line: RPMI-8226) [3]
Fulvestrant + Pentostatin DCNN6A6 Fulvestrant Invasive ductal carcinoma (Cell Line: HS 578T) [4]
Gefitinib + Pentostatin DCX29Y1 Gefitinib Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Gefitinib + Pentostatin DCBTI86 Gefitinib Amelanotic melanoma (Cell Line: M14) [3]
Gefitinib + Pentostatin DC0TEA4 Gefitinib Breast adenocarcinoma (Cell Line: MDA-MB-468) [4]
GYKI-52466 + Pentostatin DCK20ZQ GYKI-52466 Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Hepzato + Pentostatin DCQADI6 Hepzato Astrocytoma (Cell Line: U251) [3]
Hepzato + Pentostatin DCMB4TA Hepzato Clear cell renal cell carcinoma (Cell Line: 786-0) [3]
Hepzato + Pentostatin DCAVCMM Hepzato Glioma (Cell Line: SF-539) [3]
Hepzato + Pentostatin DC8JS4N Hepzato Adenocarcinoma (Cell Line: HCT-15) [5]
Hepzato + Pentostatin DC6QUFG Hepzato Cutaneous melanoma (Cell Line: SK-MEL-28) [5]
Idarubicin + Pentostatin DCGBYXS Idarubicin Clear cell renal cell carcinoma (Cell Line: 786-0) [3]
Idarubicin + Pentostatin DCBEDO3 Idarubicin Renal cell carcinoma (Cell Line: SN12C) [3]
Idarubicin + Pentostatin DCMCNBN Idarubicin Invasive ductal carcinoma (Cell Line: BT-549) [4]
Idarubicin + Pentostatin DCOIT7G Idarubicin Adenocarcinoma (Cell Line: NCIH23) [5]
Idarubicin + Pentostatin DC25U8F Idarubicin Malignant melanoma (Cell Line: LOX IMVI) [5]
Ifosfamide + Pentostatin DCG6QNA Ifosfamide Anaplastic large cell lymphoma (Cell Line: SR) [3]
Ifosfamide + Pentostatin DCBY4IZ Ifosfamide Carcinoma (Cell Line: MCF7) [4]
Ifosfamide + Pentostatin DCSBAKQ Ifosfamide Colon carcinoma (Cell Line: KM12) [4]
Imatinib + Pentostatin DCXS0JO Imatinib Adenocarcinoma (Cell Line: NCIH23) [3]
Imatinib + Pentostatin DCI3SMD Imatinib Adenocarcinoma (Cell Line: HCT-15) [3]
Imatinib + Pentostatin DCWYYA1 Imatinib Adenocarcinoma (Cell Line: HT29) [3]
Imatinib + Pentostatin DC16VE6 Imatinib Amelanotic melanoma (Cell Line: MDA-MB-435) [3]
Imatinib + Pentostatin DC14D51 Imatinib Anaplastic large cell lymphoma (Cell Line: SR) [3]
Imatinib + Pentostatin DCY39V2 Imatinib Clear cell renal cell carcinoma (Cell Line: TK-10) [3]
Imatinib + Pentostatin DCIK2TG Imatinib Lung adenocarcinoma (Cell Line: HOP-62) [3]
Indazole derivative 5 + Pentostatin DCLU4B4 Indazole derivative 5 Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Indazole derivative 5 + Pentostatin DCPBH2O Indazole derivative 5 Anaplastic large cell lymphoma (Cell Line: SR) [3]
Indazole derivative 5 + Pentostatin DCEP3B2 Indazole derivative 5 Plasma cell myeloma (Cell Line: RPMI-8226) [3]
Indazole derivative 5 + Pentostatin DCLXGVN Indazole derivative 5 Renal cell carcinoma (Cell Line: UO-31) [3]
Indazole derivative 5 + Pentostatin DCXZ4PK Indazole derivative 5 Carcinoma (Cell Line: RXF 393) [4]
Indazole derivative 5 + Pentostatin DC0PW11 Indazole derivative 5 Invasive ductal carcinoma (Cell Line: BT-549) [4]
Indazole derivative 5 + Pentostatin DC2E25E Indazole derivative 5 Adenocarcinoma (Cell Line: DU-145) [5]
Indazole derivative 5 + Pentostatin DCEENUE Indazole derivative 5 Lung adenocarcinoma (Cell Line: HOP-62) [5]
Indazole derivative 5 + Pentostatin DCTUXBK Indazole derivative 5 Lung adenocarcinoma (Cell Line: MDA-MB-231) [5]
Indazole derivative 5 + Pentostatin DCIGVM2 Indazole derivative 5 Melanoma (Cell Line: UACC-257) [5]
Indazole derivative 5 + Pentostatin DCQILY4 Indazole derivative 5 Melanoma (Cell Line: SK-MEL-2) [5]
Indazole derivative 5 + Pentostatin DCQ3ZUH Indazole derivative 5 Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [5]
Indazole derivative 5 + Pentostatin DCL2UOU Indazole derivative 5 Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [5]
Isoniazid + Pentostatin DCDIGN1 Isoniazid Amelanotic melanoma (Cell Line: MDA-MB-435) [3]
Isoniazid + Pentostatin DC8TDVF Isoniazid Chronic myelogenous leukemia (Cell Line: K-562) [3]
Isoniazid + Pentostatin DC87A1B Isoniazid Melanoma (Cell Line: SK-MEL-2) [3]
Isoniazid + Pentostatin DC87ESV Isoniazid Melanoma (Cell Line: UACC-257) [3]
IT-141 + Pentostatin DC4KC6W IT-141 Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
JNK-IN-8 + Pentostatin DC6NKMY JNK-IN-8 Clear cell renal cell carcinoma (Cell Line: A498) [3]
JNK-IN-8 + Pentostatin DC3E0NU JNK-IN-8 Renal cell carcinoma (Cell Line: SN12C) [3]
Lapatinib + Pentostatin DCVW9P5 Lapatinib Adenocarcinoma (Cell Line: HCT-15) [5]
Lapatinib + Pentostatin DCL074P Lapatinib Chronic myelogenous leukemia (Cell Line: K-562) [5]
Lapatinib + Pentostatin DC9CQAW Lapatinib Glioma (Cell Line: SF-539) [5]
Lefaxin + Pentostatin DC35SDY Lefaxin Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Lenalidomide + Pentostatin DC8WAKP Lenalidomide Adenocarcinoma (Cell Line: SW-620) [5]
Lenalidomide + Pentostatin DC4YOHS Lenalidomide Adenocarcinoma (Cell Line: HCC-2998) [5]
Lenalidomide + Pentostatin DCTJEFW Lenalidomide Cutaneous melanoma (Cell Line: SK-MEL-5) [5]
Lenalidomide + Pentostatin DC4GAVU Lenalidomide Cutaneous melanoma (Cell Line: SK-MEL-28) [5]
Lenalidomide + Pentostatin DC9W6JK Lenalidomide Melanoma (Cell Line: UACC-257) [5]
Letrozole + Pentostatin DCHQW7C Letrozole Amelanotic melanoma (Cell Line: MDA-MB-435) [3]
Letrozole + Pentostatin DCFXWJW Letrozole Lung adenocarcinoma (Cell Line: EKVX) [3]
Letrozole + Pentostatin DC98DAA Letrozole Melanoma (Cell Line: UACC-257) [3]
Letrozole + Pentostatin DC5THDD Letrozole Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [3]
Letrozole + Pentostatin DCURN9D Letrozole Plasma cell myeloma (Cell Line: RPMI-8226) [3]
Letrozole + Pentostatin DCGLA15 Letrozole Colon adenocarcinoma (Cell Line: COLO 205) [4]
LIAROZOLE + Pentostatin DCBV33M LIAROZOLE Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [3]
LIAROZOLE + Pentostatin DC15S25 LIAROZOLE Chronic myelogenous leukemia (Cell Line: K-562) [3]
LIAROZOLE + Pentostatin DCYCVQP LIAROZOLE Renal cell carcinoma (Cell Line: SN12C) [3]
LIAROZOLE + Pentostatin DC3DPOZ LIAROZOLE Breast adenocarcinoma (Cell Line: MDA-MB-468) [4]
LIAROZOLE + Pentostatin DC14P0Q LIAROZOLE Colon carcinoma (Cell Line: KM12) [4]
LIAROZOLE + Pentostatin DCBX66D LIAROZOLE Invasive ductal carcinoma (Cell Line: BT-549) [4]
LIAROZOLE + Pentostatin DCQS4H1 LIAROZOLE Adenocarcinoma (Cell Line: A549) [5]
LIAROZOLE + Pentostatin DCXHG8X LIAROZOLE Adenocarcinoma (Cell Line: HCT116) [5]
LIAROZOLE + Pentostatin DCO61GR LIAROZOLE Lung adenocarcinoma (Cell Line: HOP-62) [5]
LIAROZOLE + Pentostatin DC8F2FW LIAROZOLE Lung adenocarcinoma (Cell Line: NCI-H522) [5]
Maprotiline + Pentostatin DC3XHE0 Maprotiline Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Mechlorethamine + Pentostatin DCZNS00 Mechlorethamine Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Mechlorethamine + Pentostatin DCVGN33 Mechlorethamine Melanoma (Cell Line: SK-MEL-2) [5]
Memantine + Pentostatin DCHG4KT Memantine Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Mepacrine + Pentostatin DCF894Y Mepacrine Astrocytoma (Cell Line: U251) [3]
Mepacrine + Pentostatin DC0JL64 Mepacrine Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [3]
Mepacrine + Pentostatin DCJCZP5 Mepacrine Clear cell renal cell carcinoma (Cell Line: TK-10) [3]
Mepacrine + Pentostatin DCIPFI6 Mepacrine Breast adenocarcinoma (Cell Line: MDA-MB-468) [4]
Mepacrine + Pentostatin DCFHGBT Mepacrine Adenocarcinoma (Cell Line: HCT-15) [5]
Mepacrine + Pentostatin DC1F2Z7 Mepacrine Melanoma (Cell Line: UACC-257) [5]
Mercaptopurine + Pentostatin DCC9VHM Mercaptopurine Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Mercaptopurine + Pentostatin DC25TB9 Mercaptopurine Chronic myelogenous leukemia (Cell Line: K-562) [3]
Mercaptopurine + Pentostatin DCTSZZ4 Mercaptopurine Renal cell carcinoma (Cell Line: UO-31) [3]
Methotrexate + Pentostatin DCU48OJ Methotrexate Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Methotrexate + Pentostatin DC0X6DO Methotrexate Invasive ductal carcinoma (Cell Line: HS 578T) [4]
Mitomycin + Pentostatin DCNB36D Mitomycin Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Mitomycin + Pentostatin DCZ7000 Mitomycin Astrocytoma (Cell Line: SNB-19) [3]
Mitomycin + Pentostatin DCHBSUW Mitomycin Glioma (Cell Line: SF-539) [3]
Mitomycin + Pentostatin DC912TA Mitomycin Glioma (Cell Line: SF-268) [3]
Mitomycin + Pentostatin DC8QGOV Mitomycin Carcinoma (Cell Line: MCF7) [4]
Mitomycin + Pentostatin DC8VX4L Mitomycin Adenocarcinoma (Cell Line: HCC-2998) [5]
Mitomycin + Pentostatin DC6GRZQ Mitomycin Cutaneous melanoma (Cell Line: SK-MEL-28) [5]
Mitomycin + Pentostatin DCYW788 Mitomycin High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [5]
Mycophenolic acid + Pentostatin DCLLXCK Mycophenolic acid Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Nilotinib + Pentostatin DCCILJC Nilotinib Clear cell renal cell carcinoma (Cell Line: A498) [3]
Nilotinib + Pentostatin DCRP0GR Nilotinib Glioma (Cell Line: SF-539) [3]
Nilotinib + Pentostatin DCRHIVM Nilotinib Plasma cell myeloma (Cell Line: RPMI-8226) [3]
Nilotinib + Pentostatin DCCA1Q6 Nilotinib Amelanotic melanoma (Cell Line: MDA-MB-435) [5]
Nilotinib + Pentostatin DCQT47V Nilotinib High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4) [5]
Nilotinib + Pentostatin DCYFR6P Nilotinib Large cell lung carcinoma (Cell Line: NCI-H460) [5]
Nilotinib + Pentostatin DCGCZLJ Nilotinib Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [5]
Nilotinib + Pentostatin DCEJQU1 Nilotinib Non-small cell lung carcinoma (Cell Line: HOP-92) [5]
Nilotinib + Pentostatin DC4XGI6 Nilotinib Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [5]
Nitisinone + Pentostatin DCF1UNE Nitisinone Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Pentostatin + Bepridil DCP6QC7 Bepridil Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Pentostatin + Dantrolene DC7UV5U Dantrolene Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Pentostatin + Kanamycin DC893MI Kanamycin Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Pentostatin + Ixabepilone DCXPZI3 Ixabepilone Adenocarcinoma (Cell Line: SW-620) [3]
Pentostatin + Ixabepilone DCTVMVH Ixabepilone Adenocarcinoma (Cell Line: HCT116) [3]
Pentostatin + Ixabepilone DC20SL7 Ixabepilone Cutaneous melanoma (Cell Line: SK-MEL-28) [3]
Pentostatin + PMID28460551-Compound-2 DCMT3V1 PMID28460551-Compound-2 Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Pentostatin + Vinblastine DC44GCX Vinblastine Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Pentostatin + Arsenic trioxide DCPZV47 Arsenic trioxide Cutaneous melanoma (Cell Line: SK-MEL-5) [3]
Pentostatin + Arsenic trioxide DCPNI3N Arsenic trioxide Melanoma (Cell Line: UACC-257) [3]
Pentostatin + Anamorelin DCURQZQ Anamorelin Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Pentostatin + Marizomib DCW1IE8 Marizomib Diffuse intrinsic pontine glioma (Cell Line: DIPG25) [3]
Pentostatin + Phensuximide DCEC1K4 Phensuximide Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Pentostatin + Ciprofibrate DCCSGCP Ciprofibrate Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Pentostatin + GINKGOLIDE A DCSB1LS GINKGOLIDE A Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Pentostatin + Diazoxide DCSPG6V Diazoxide Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Pentostatin + Bortezomib DCJDJC0 Bortezomib Glioma (Cell Line: SF-268) [3]
Pentostatin + Bortezomib DCOPF29 Bortezomib Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [3]
Pentostatin + Methylene blue DC2ITJ2 Methylene blue Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Pentostatin + Leflunomide DCAJQPC Leflunomide Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Pentostatin + Cisplatin DCEQ9HQ Cisplatin Adenocarcinoma (Cell Line: A549) [3]
Pentostatin + Cisplatin DCC9IBR Cisplatin Adenocarcinoma (Cell Line: HT29) [3]
Pentostatin + Cisplatin DCOE8ZF Cisplatin Adenocarcinoma (Cell Line: HCC-2998) [3]
Pentostatin + Cisplatin DCUNN67 Cisplatin Glioma (Cell Line: SF-539) [3]
Pentostatin + Cisplatin DCC2AUQ Cisplatin High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [3]
Pentostatin + Cisplatin DCE2DN8 Cisplatin High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [3]
Pentostatin + Cisplatin DC27VIW Cisplatin Melanoma (Cell Line: SK-MEL-2) [3]
Pentostatin + Cisplatin DCWRDOQ Cisplatin Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [3]
Pentostatin + Chlorambucil DCI87NQ Chlorambucil Adenocarcinoma (Cell Line: OVCAR3) [3]
Pentostatin + Chlorambucil DCA0453 Chlorambucil Clear cell renal cell carcinoma (Cell Line: CAKI-1) [3]
Pentostatin + Chlorambucil DCADHYK Chlorambucil Lung adenocarcinoma (Cell Line: EKVX) [3]
Pentostatin + Chlorambucil DCHX2PW Chlorambucil Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [3]
Pentostatin + Chlorambucil DC0ZPO7 Chlorambucil Papillary renal cell carcinoma (Cell Line: ACHN) [3]
Pentostatin + Brincidofovir DCO74KI Brincidofovir Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Pentostatin + Mefloquine DCG20FA Mefloquine Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Pentostatin + Vorinostat DCRWT0I Vorinostat Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Pentostatin + Estramustine DC9C0N1 Estramustine Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Pentostatin + Acetohydroxamic Acid DCBJJVR Acetohydroxamic Acid Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Pentostatin + Cytarabine DC9BI0D Cytarabine Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Pentostatin + Ixabepilone DCYE7WZ Ixabepilone Invasive ductal carcinoma (Cell Line: T-47D) [4]
Pentostatin + Cisplatin DCT8V8M Cisplatin Carcinoma (Cell Line: RXF 393) [4]
Plicamycin + Pentostatin DCBTF8M Plicamycin Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Plicamycin + Pentostatin DCRXY29 Plicamycin Astrocytoma (Cell Line: U251) [3]
Plicamycin + Pentostatin DC7YUH9 Plicamycin Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [3]
Plicamycin + Pentostatin DCAMIDT Plicamycin Chronic myelogenous leukemia (Cell Line: K-562) [3]
Plicamycin + Pentostatin DCTQUY7 Plicamycin Glioma (Cell Line: SF-539) [3]
Plicamycin + Pentostatin DCJU590 Plicamycin Renal cell carcinoma (Cell Line: UO-31) [3]
Plicamycin + Pentostatin DCIOVC4 Plicamycin Renal cell carcinoma (Cell Line: SN12C) [3]
Plicamycin + Pentostatin DCQNE4V Plicamycin Adenocarcinoma (Cell Line: HT29) [5]
Plicamycin + Pentostatin DCQBMCZ Plicamycin Adenocarcinoma (Cell Line: SW-620) [5]
Plicamycin + Pentostatin DCVBEG5 Plicamycin Large cell lung carcinoma (Cell Line: NCI-H460) [5]
Plicamycin + Pentostatin DCRPL76 Plicamycin Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [5]
PMID28460551-Compound-2 + Pentostatin DC4DSMF PMID28460551-Compound-2 Astrocytoma (Cell Line: SNB-19) [3]
PMID28460551-Compound-2 + Pentostatin DC618MO PMID28460551-Compound-2 Clear cell renal cell carcinoma (Cell Line: TK-10) [3]
PMID28460551-Compound-2 + Pentostatin DCW4MFV PMID28460551-Compound-2 Adenocarcinoma (Cell Line: HCC-2998) [5]
PMID28870136-Compound-43 + Pentostatin DCMLSI2 PMID28870136-Compound-43 Astrocytoma (Cell Line: U251) [3]
PMID28870136-Compound-43 + Pentostatin DCZ7ROT PMID28870136-Compound-43 Glioblastoma (Cell Line: SNB-75) [3]
PMID28870136-Compound-43 + Pentostatin DC8CYNH PMID28870136-Compound-43 Adenocarcinoma (Cell Line: HCT116) [5]
PMID28870136-Compound-43 + Pentostatin DCJ6DVC PMID28870136-Compound-43 Amelanotic melanoma (Cell Line: MDA-MB-435) [5]
Pomalidomide + Pentostatin DC3C3UW Pomalidomide Adenocarcinoma (Cell Line: HCC-2998) [3]
Pomalidomide + Pentostatin DC8DWJQ Pomalidomide Amelanotic melanoma (Cell Line: MDA-MB-435) [3]
Pomalidomide + Pentostatin DCR3KEJ Pomalidomide Anaplastic large cell lymphoma (Cell Line: SR) [3]
Pomalidomide + Pentostatin DC6LVQJ Pomalidomide Lung adenocarcinoma (Cell Line: NCI-H522) [3]
Pomalidomide + Pentostatin DCBWGAC Pomalidomide Carcinoma (Cell Line: MCF7) [4]
Pomalidomide + Pentostatin DCBG2H3 Pomalidomide Invasive ductal carcinoma (Cell Line: BT-549) [4]
Pralatrexate + Pentostatin DCFHLZT Pralatrexate Astrocytoma (Cell Line: U251) [3]
Pralatrexate + Pentostatin DCNCH59 Pralatrexate Glioblastoma (Cell Line: SNB-75) [3]
Pralatrexate + Pentostatin DCO8QA8 Pralatrexate Colon carcinoma (Cell Line: KM12) [4]
Pralatrexate + Pentostatin DC2ILR1 Pralatrexate Adenocarcinoma (Cell Line: HCT116) [5]
Pralatrexate + Pentostatin DCI5TA6 Pralatrexate High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4) [5]
Pralatrexate + Pentostatin DCLUHPB Pralatrexate Melanoma (Cell Line: SK-MEL-2) [5]
Pralatrexate + Pentostatin DC39TRE Pralatrexate Melanoma (Cell Line: UACC-257) [5]
Raloxifene + Pentostatin DC57131 Raloxifene Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Raloxifene + Pentostatin DCJ5Q8U Raloxifene Plasma cell myeloma (Cell Line: RPMI-8226) [3]
Raloxifene + Pentostatin DCMVMYA Raloxifene Invasive ductal carcinoma (Cell Line: BT-549) [4]
Raloxifene + Pentostatin DCPLRVM Raloxifene Invasive ductal carcinoma (Cell Line: HS 578T) [4]
Raloxifene + Pentostatin DCR2DUC Raloxifene Adenocarcinoma (Cell Line: NCIH23) [5]
Raloxifene + Pentostatin DCU8SVH Raloxifene Adenocarcinoma (Cell Line: HCT116) [5]
Raloxifene + Pentostatin DCTJLFC Raloxifene Adenocarcinoma (Cell Line: HCT-15) [5]
Raloxifene + Pentostatin DCBVE4A Raloxifene Cutaneous melanoma (Cell Line: SK-MEL-28) [5]
Raloxifene + Pentostatin DCBSK5F Raloxifene High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [5]
Raloxifene + Pentostatin DCEEDM5 Raloxifene Lung adenocarcinoma (Cell Line: HOP-62) [5]
Raloxifene + Pentostatin DC0XB3Q Raloxifene Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [5]
Ruxolitinib + Pentostatin DCGJJ9S Ruxolitinib Glioma (Cell Line: SF-268) [3]
Ruxolitinib + Pentostatin DC82ARE Ruxolitinib Plasma cell myeloma (Cell Line: RPMI-8226) [3]
Ruxolitinib + Pentostatin DCM5DSN Ruxolitinib Invasive ductal carcinoma (Cell Line: HS 578T) [4]
Ruxolitinib + Pentostatin DCLJ7V9 Ruxolitinib Invasive ductal carcinoma (Cell Line: T-47D) [4]
Ruxolitinib + Pentostatin DCZGMOZ Ruxolitinib Invasive ductal carcinoma (Cell Line: BT-549) [4]
Ruxolitinib + Pentostatin DCO4RBH Ruxolitinib Adenocarcinoma (Cell Line: HCT-15) [5]
Ruxolitinib + Pentostatin DCXW6O8 Ruxolitinib Amelanotic melanoma (Cell Line: MDA-MB-435) [5]
Ruxolitinib + Pentostatin DCVXAI4 Ruxolitinib Cutaneous melanoma (Cell Line: SK-MEL-28) [5]
Ruxolitinib + Pentostatin DCLAMZI Ruxolitinib High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [5]
Ruxolitinib + Pentostatin DCR7IDY Ruxolitinib High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [5]
Ruxolitinib + Pentostatin DC6N9PD Ruxolitinib Large cell lung carcinoma (Cell Line: NCI-H460) [5]
Ruxolitinib + Pentostatin DCFJ4NS Ruxolitinib Melanoma (Cell Line: SK-MEL-2) [5]
Ruxolitinib + Pentostatin DCJO7UZ Ruxolitinib Melanoma (Cell Line: MALME-3M) [5]
SCH 727965 + Pentostatin DCVW99F SCH 727965 Colon adenocarcinoma (Cell Line: COLO 205) [4]
SCH 727965 + Pentostatin DCBF9MY SCH 727965 Adenocarcinoma (Cell Line: HCT-15) [5]
Sirolimus + Pentostatin DCYC368 Sirolimus Adenocarcinoma (Cell Line: HCT-15) [5]
Sorafenib + Pentostatin DCE2E52 Sorafenib Adenocarcinoma (Cell Line: HT29) [3]
Sorafenib + Pentostatin DC4LZ9A Sorafenib Anaplastic large cell lymphoma (Cell Line: SR) [3]
Sorafenib + Pentostatin DCTPGIV Sorafenib Clear cell renal cell carcinoma (Cell Line: A498) [3]
Sorafenib + Pentostatin DC157DE Sorafenib Clear cell renal cell carcinoma (Cell Line: 786-0) [3]
Sorafenib + Pentostatin DCUGY1G Sorafenib Large cell lung carcinoma (Cell Line: NCI-H460) [3]
Sorafenib + Pentostatin DCCO1XX Sorafenib Melanoma (Cell Line: UACC-257) [3]
Sorafenib + Pentostatin DCUXLNC Sorafenib Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [3]
Sorafenib + Pentostatin DCS5NYQ Sorafenib Plasma cell myeloma (Cell Line: RPMI-8226) [3]
Sorafenib + Pentostatin DCU3A13 Sorafenib Colon carcinoma (Cell Line: KM12) [4]
Sumatriptan + Pentostatin DCKK0Y3 Sumatriptan Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
SY-1425 + Pentostatin DCYBKX0 SY-1425 Anaplastic large cell lymphoma (Cell Line: SR) [3]
SY-1425 + Pentostatin DCMRBUI SY-1425 Renal cell carcinoma (Cell Line: SN12C) [3]
SY-1425 + Pentostatin DCN7ATE SY-1425 Invasive ductal carcinoma (Cell Line: BT-549) [4]
SY-1425 + Pentostatin DCOIA4L SY-1425 Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [5]
Taxol + Pentostatin DC6WWTG Taxol Adenocarcinoma (Cell Line: HCT-15) [5]
TEM + Pentostatin DCBR687 TEM Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
TEM + Pentostatin DCHZUNG TEM Clear cell renal cell carcinoma (Cell Line: A498) [3]
TEM + Pentostatin DCW8RMC TEM Glioma (Cell Line: SF-539) [3]
TEM + Pentostatin DC142LO TEM Carcinoma (Cell Line: RXF 393) [4]
TEM + Pentostatin DC3IXES TEM Colon adenocarcinoma (Cell Line: COLO 205) [4]
TEM + Pentostatin DCDWS2U TEM Invasive ductal carcinoma (Cell Line: HS 578T) [4]
TEM + Pentostatin DC7R8BR TEM Adenocarcinoma (Cell Line: HCT-15) [5]
TEM + Pentostatin DCR6041 TEM Amelanotic melanoma (Cell Line: MDA-MB-435) [5]
TEM + Pentostatin DCLK6HM TEM High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [5]
TEM + Pentostatin DC25OME TEM Lung adenocarcinoma (Cell Line: EKVX) [5]
TEM + Pentostatin DC16Z77 TEM Melanoma (Cell Line: MALME-3M) [5]
TEM + Pentostatin DC02LMR TEM Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [5]
Terameprocol + Pentostatin DCXOWQU Terameprocol Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [3]
Terameprocol + Pentostatin DCHEVWW Terameprocol Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Terameprocol + Pentostatin DC6TCQB Terameprocol Clear cell renal cell carcinoma (Cell Line: A498) [3]
Terameprocol + Pentostatin DCZ0S6X Terameprocol Clear cell renal cell carcinoma (Cell Line: CAKI-1) [3]
Terameprocol + Pentostatin DCPK9J5 Terameprocol Invasive ductal carcinoma (Cell Line: BT-549) [4]
Terameprocol + Pentostatin DC762M3 Terameprocol Adenocarcinoma (Cell Line: SW-620) [5]
Terameprocol + Pentostatin DCYWCHE Terameprocol Adenocarcinoma (Cell Line: HCT-15) [5]
Terameprocol + Pentostatin DCZXTUL Terameprocol Large cell lung carcinoma (Cell Line: NCI-H460) [5]
Thioguanine + Pentostatin DCK3BWU Thioguanine Clear cell renal cell carcinoma (Cell Line: CAKI-1) [3]
Tiagabine + Pentostatin DCSA3KO Tiagabine Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Topotecan + Pentostatin DCLLXR2 Topotecan Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [5]
Topotecan + Pentostatin DCNJOYT Topotecan Amelanotic melanoma (Cell Line: M14) [5]
Topotecan + Pentostatin DCDCZCL Topotecan Astrocytoma (Cell Line: SNB-19) [5]
Topotecan + Pentostatin DCF1X44 Topotecan Chronic myelogenous leukemia (Cell Line: KBM-7) [5]
Topotecan + Pentostatin DCUTNAU Topotecan Clear cell renal cell carcinoma (Cell Line: CAKI-1) [5]
Topotecan + Pentostatin DC9IP2A Topotecan Glioma (Cell Line: SF-268) [5]
Topotecan + Pentostatin DCGYU9B Topotecan Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [5]
Topotecan + Pentostatin DCGQPS1 Topotecan Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [5]
Triapine + Pentostatin DCAFSIZ Triapine Invasive ductal carcinoma (Cell Line: BT-549) [4]
Triapine + Pentostatin DCJYQ2Y Triapine Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [5]
Triapine + Pentostatin DCE3IFG Triapine Anaplastic large cell lymphoma (Cell Line: SR) [5]
Triapine + Pentostatin DC3R7XO Triapine Astrocytoma (Cell Line: U251) [5]
Triapine + Pentostatin DCBM6U9 Triapine Clear cell renal cell carcinoma (Cell Line: TK-10) [5]
Triapine + Pentostatin DC60K25 Triapine Renal cell carcinoma (Cell Line: UO-31) [5]
Trimethobenzamide + Pentostatin DCZCORE Trimethobenzamide Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Trioxsalen + Pentostatin DCMOM7O Trioxsalen Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Valrubicin + Pentostatin DCY5M5K Valrubicin Clear cell renal cell carcinoma (Cell Line: CAKI-1) [3]
Valrubicin + Pentostatin DCS9BPS Valrubicin Amelanotic melanoma (Cell Line: MDA-MB-435) [5]
Valrubicin + Pentostatin DCYJDR4 Valrubicin High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [5]
Valrubicin + Pentostatin DCFZ5TA Valrubicin Lung adenocarcinoma (Cell Line: EKVX) [5]
Valrubicin + Pentostatin DC50Y2J Valrubicin Melanoma (Cell Line: MALME-3M) [5]
Vandetanib + Pentostatin DC5CROC Vandetanib Breast adenocarcinoma (Cell Line: MDA-MB-468) [4]
Vandetanib + Pentostatin DCX1ZSJ Vandetanib Colon adenocarcinoma (Cell Line: COLO 205) [4]
Vandetanib + Pentostatin DCKWEFS Vandetanib Invasive ductal carcinoma (Cell Line: HS 578T) [4]
Vandetanib + Pentostatin DCFTW0A Vandetanib Invasive ductal carcinoma (Cell Line: BT-549) [4]
Vandetanib + Pentostatin DCCH70O Vandetanib Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [5]
Vandetanib + Pentostatin DCMX7CK Vandetanib Amelanotic melanoma (Cell Line: MDA-MB-435) [5]
Vandetanib + Pentostatin DCWHKSH Vandetanib Amelanotic melanoma (Cell Line: M14) [5]
Vandetanib + Pentostatin DC257UP Vandetanib Clear cell renal cell carcinoma (Cell Line: 786-0) [5]
Vandetanib + Pentostatin DCPWUJ8 Vandetanib Cutaneous melanoma (Cell Line: SK-MEL-28) [5]
Vandetanib + Pentostatin DCPKOPK Vandetanib Melanoma (Cell Line: SK-MEL-2) [5]
Vandetanib + Pentostatin DCDT3XY Vandetanib Plasma cell myeloma (Cell Line: RPMI-8226) [5]
Vemurafenib + Pentostatin DCKBTCJ Vemurafenib Invasive ductal carcinoma (Cell Line: HS 578T) [4]
Vemurafenib + Pentostatin DC5GTFG Vemurafenib Invasive ductal carcinoma (Cell Line: BT-549) [4]
Vemurafenib + Pentostatin DCK50IU Vemurafenib Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [5]
Vemurafenib + Pentostatin DC6H2BG Vemurafenib Astrocytoma (Cell Line: SNB-19) [5]
Vemurafenib + Pentostatin DCM8DEE Vemurafenib Clear cell renal cell carcinoma (Cell Line: A498) [5]
Vemurafenib + Pentostatin DCXO75Y Vemurafenib Glioma (Cell Line: SF-268) [5]
Vemurafenib + Pentostatin DCLW2DD Vemurafenib High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [5]
Vemurafenib + Pentostatin DCV6ASP Vemurafenib Melanoma (Cell Line: SK-MEL-2) [5]
Vemurafenib + Pentostatin DC4PXB7 Vemurafenib Plasma cell myeloma (Cell Line: RPMI-8226) [5]
Vemurafenib + Pentostatin DCL5P1H Vemurafenib Renal cell carcinoma (Cell Line: UO-31) [5]
Vincristine + Pentostatin DCS15D5 Vincristine Adenocarcinoma (Cell Line: HT29) [3]
Vincristine + Pentostatin DC8N57C Vincristine Clear cell renal cell carcinoma (Cell Line: CAKI-1) [3]
Vincristine + Pentostatin DCSRH1T Vincristine Colon adenocarcinoma (Cell Line: COLO 205) [4]
Vinflunine + Pentostatin DCSDWSD Vinflunine Anaplastic large cell lymphoma (Cell Line: SR) [3]
Vinflunine + Pentostatin DC63EUD Vinflunine Clear cell renal cell carcinoma (Cell Line: CAKI-1) [3]
Vinflunine + Pentostatin DCLB66M Vinflunine Plasma cell myeloma (Cell Line: RPMI-8226) [3]
Vinflunine + Pentostatin DCVUWRB Vinflunine Renal cell carcinoma (Cell Line: UO-31) [3]
Vinflunine + Pentostatin DCEA5WP Vinflunine High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [5]
Vinflunine + Pentostatin DCCSMQ8 Vinflunine High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [5]
Vinflunine + Pentostatin DCU4WVF Vinflunine Malignant melanoma (Cell Line: LOX IMVI) [5]
Vinflunine + Pentostatin DC35V15 Vinflunine Malignant melanoma (Cell Line: UACC62) [5]
Vinflunine + Pentostatin DCFTKAJ Vinflunine Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [5]
Vinflunine + Pentostatin DC6NQGY Vinflunine Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [5]
Vismodegib + Pentostatin DCY63S3 Vismodegib Colon adenocarcinoma (Cell Line: COLO 205) [4]
Vismodegib + Pentostatin DCRBK2W Vismodegib Invasive ductal carcinoma (Cell Line: HS 578T) [4]
Vismodegib + Pentostatin DC7SOMA Vismodegib Invasive ductal carcinoma (Cell Line: BT-549) [4]
Vismodegib + Pentostatin DCJI2PH Vismodegib Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [5]
Vismodegib + Pentostatin DCPITGU Vismodegib Amelanotic melanoma (Cell Line: M14) [5]
Vismodegib + Pentostatin DCUQZQ8 Vismodegib Clear cell renal cell carcinoma (Cell Line: 786-0) [5]
Vismodegib + Pentostatin DCAYH9P Vismodegib Cutaneous melanoma (Cell Line: SK-MEL-5) [5]
Vismodegib + Pentostatin DC5KC75 Vismodegib Cutaneous melanoma (Cell Line: SK-MEL-28) [5]
Vismodegib + Pentostatin DC85SUZ Vismodegib Glioblastoma (Cell Line: SNB-75) [5]
Vismodegib + Pentostatin DC69W7F Vismodegib High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [5]
Vismodegib + Pentostatin DCG79E1 Vismodegib Large cell lung carcinoma (Cell Line: NCI-H460) [5]
Vismodegib + Pentostatin DCJX3SM Vismodegib Lung adenocarcinoma (Cell Line: HOP-62) [5]
Vismodegib + Pentostatin DCSR8WJ Vismodegib Malignant melanoma (Cell Line: LOX IMVI) [5]
Vismodegib + Pentostatin DCYK8MF Vismodegib Melanoma (Cell Line: UACC-257) [5]
Vismodegib + Pentostatin DCJ3JGJ Vismodegib Renal cell carcinoma (Cell Line: UO-31) [5]
WAY-100635 + Pentostatin DCXG0QX WAY-100635 Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Zaleplon + Pentostatin DC7COW5 Zaleplon Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
------------------------------------------------------------------------------------
⏷ Show the Full List of 456 DrugCom(s)
5 Clinical Trial Drug Combination(s) Consisting of This drug
DrugCom Name DrugCom ID Component Drug Indication REF
Pentostatin + Cyclophosphamide DC7UH9A Cyclophosphamide Chronic Lymphocytic Leukemia [6]
Pentostatin + Cyclophosphamide DCJ47KC Cyclophosphamide Mesothelioma [7]
Pentostatin + Cyclophosphamide DCW64MQ Cyclophosphamide Leukemia [8]
Pentostatin + Methotrexate DC67YIW Methotrexate Leukemia [9]
Pentostatin + Mycophenolate mofetil DCFV0UE Mycophenolate mofetil Acute Lymphoblastic Leukemia [10]
------------------------------------------------------------------------------------

References

1 Pentostatin FDA Label
2 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4805).
3 Recurrent recessive mutation in deoxyguanosine kinase causes idiopathic noncirrhotic portal hypertension.Hepatology. 2016 Jun;63(6):1977-86. doi: 10.1002/hep.28499. Epub 2016 Mar 31.
4 Biologically active neutrophil chemokine pattern in tonsillitis.Clin Exp Immunol. 2004 Mar;135(3):511-8. doi: 10.1111/j.1365-2249.2003.02390.x.
5 Loss of function mutations in VARS encoding cytoplasmic valyl-tRNA synthetase cause microcephaly, seizures, and progressive cerebral atrophy.Hum Genet. 2018 Apr;137(4):293-303. doi: 10.1007/s00439-018-1882-3. Epub 2018 Apr 24.
6 ClinicalTrials.gov (NCT01024010) Ofatumumab, Pentostatin, and Cyclophosphamide in Treating Patients With Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
7 ClinicalTrials.gov (NCT01362790) SS1P and Pentostatin Plus Cyclophosphamide for Mesothelioma
8 ClinicalTrials.gov (NCT00074282) Pentostatin, Cyclophosphamide, and Rituximab Followed By Campath-1H in Patients With Relapsed or Refractory B-Cell CLL
9 ClinicalTrials.gov (NCT00506922) Phase I/II Study of Pentostatin Combined With Tacrolimus and Mini-Methotrexate for GVHD Prevention After MUD BMT
10 ClinicalTrials.gov (NCT00096161) Pentostatin and Lymphocyte Infusion in Preventing Graft Rejection in Patients Who Have Undergone Donor Stem Cell Transplant